Join
Live feed
·
INSIDERFilingvia Quantisnow
Intra-Cellular Therapies Inc. logo

Neumann Mark converted options into 13,132 shares, increasing direct ownership by 44% to 42,832 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ITCI· Intra-Cellular Therapies Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ITCI (Intra-Cellular Therapies Inc.) and more on Quantisnow.